Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
amgen
biotech
boston blog main
boston top stories
cancer
cancer drugs
clinical trials
cobimetinib
1
×
deals
1
×
investing
ipo
life sciences
national blog main
national top stories
revolution medicines
roche
1
×
san francisco
san francisco blog main
san francisco top stories
sanofi
the column group
third rock ventures
university of illinois
venture capital
warp drive bio
What
cancer
despite
1
×
drug
1
×
family
hardest
hit
hottest
hunters
ipo
medicines
proteins
ras
reels
research
revolution
targets
Language
unset
1
×
Current search:
cobimetinib
×
drug
×
unset
×
deals
×
roche
×
despite
×
@xconomy.com
4 years ago
Revolution Medicines IPO Reels In $238M to Take On RAS in Cancer